Metrics
Publication
99
Open Access
13
UN Sustainable Development Goals
Education
2022 - Present
2022 - PresentDoctorate
Istanbul University, Health Sciences Institute, Aziz Sancar Deneysel Tıp Araştırma Enstitüsü Bölümü, Turkey
2016 - 2020
2016 - 2020Expertise In Medicine
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey
2009 - 2015
2009 - 2015Undergraduate
Istanbul University, Istanbul Medical Faculty, Tip, Turkey
Dissertations
2020
2020Expertise In Medicine
Sistemik lupus eritematozus'lu hastalarda pulmoner tutulum
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
Research Areas
Health Sciences
Academic Positions
2024 - Present
2024 - PresentAssociate Professor
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
2022 - 2024
2022 - 2024Assistant Professor
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
2016 - 2020
2016 - 2020Research Assistant PhD
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
Non Academic Experience
2020 - 2022
2020 - 2022Başhekim
Public Hospital, SAĞLIK BAKANLIĞI ELEŞKİRT DEVLET HASTANESİ, Başhekimlik, Başhekim
Articles
All (55)
SCI-E, SSCI, AHCI (39)
SCI-E, SSCI, AHCI, ESCI (48)
ESCI (8)
Scopus (45)
TRDizin (13)
Other Publications (2)
2025
20251. Association of Apolipoprotein C-III Gene Polymorphisms (rs2854116 and rs2854117) with Susceptibility to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Turkish Population
KARAAĞAÇ D., MORKUZU S., ŞENKAL N., BİLGİN E., Oyaci Y., TÜKEK T., et al.
MEDICINA-LITHUANIA
, vol.61, no.8, 2025 (SCI-Expanded)
2025
20252. Investigation of prolonged PCR positivity in COVID-19 patients.
Allahverdiyeva A., Mese S., Senkal N., Medetalibeyoglu A., Onel M., Uysal H., et al.
Medicine
, vol.104, no.30, 2025 (SCI-Expanded, Scopus)
2025
20253. Radiologic and Clinical Correlates of Long-Term Post-COVID-19 Pulmonary Sequelae
Durak G., Akin K., Cetin O., Uysal E., Aktas H. E., Durak U., et al.
Journal of Clinical Medicine
, vol.14, no.14, 2025 (SCI-Expanded)
2025
20254. Analysis genomic profiles of type 2 diabetes patients with COVID-19 by next-generation sequencing method in Turkish population
CACINA C., ÇAKİRİS A., ABACI N., SIRMA EKMEKCİ S., BAYRAK A. E., MEDETALİBEYOĞLU A., et al.
FEBS OPEN BIO
, vol.15, pp.112, 2025 (SCI-Expanded)
2025
20255. Potential Predictors of the Outcome of Tocilizumab Treatment in Patients with COVID-19-Associated Hyperinflammation
AMIKISHIYEV S., BEKTAŞ M., GÜNVER M. G., İNCE B., Aghamuradov S., Koca N., et al.
INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY
, vol.7, no.2, pp.185-194, 2025 (ESCI)
2025
20256. Metabolic syndrome and effect of gene polymorphisms: ADIPOQ, AGT, AGTR1, AGTR2, ApoC-III, NR3C1 and GNB3 gene polymorphisms.
Pehlivan S., Senkal N., Oyaci Y., Kose M., Pehlivan M., Hasanoglu Sayin S., et al.
Molecular biology reports
, vol.52, no.1, pp.422, 2025 (SCI-Expanded)
2025
20257. Evaluation of Acute Enteritis Cases in Adults Presenting to the Emergency Department: A Single Tertiary Care Hospital Experience
DIRIM M. G., Senkal N., Konyaoğlu H., akın k., Emekdaş B., Medetalibeyoglu A., et al.
Sakarya Tıp Dergisi
, vol.15, no.1, pp.16-22, 2025 (Peer-Reviewed Journal)
2025
20258. Multifocal Intestinal Extranodal Marginal Zone Lymphoma Presenting With Autoimmune Hemolytic Anemia: A Case Report
Bardak A. E., Senkal N., Nuriyev K., Medetalibeyoglu A.
Annals of Internal Medicine Clinical Cases
, vol.4, no.3, 2025 (Scopus)
2025
20259. Aseptic Abscess Syndrome: A Unique Case of Splenic Involvement and Systemic Inflammation.
Yılmaz B., Güzel Dirim M., Gültekin B., Şenkal N., Medetalibeyoğlu A., Yegen G., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, vol.42, no.1, pp.72-73, 2025 (SCI-Expanded)
2024
202410. A rare multisystemic disorder with chronic kidney disease: Karyomegalic interstitial nephritis due to homozygous FAN1 c.2260C>T variant
Guzel Dirim M., Dirim A. B., Kaya B., Senkal N., Kalayci T., Aslanger A. D., et al.
NEPHROLOGY
, vol.29, no.12, pp.968-972, 2024 (SCI-Expanded)
2024
202411. A descriptive analysis of 21 patients with pulmonary amyloidosis An observational study
Demirkol B., Satici C., Eren R., Ugur Chousein E. G., Senkal N., Turan D., et al.
Medicine (United States)
, vol.103, no.45, 2024 (SCI-Expanded)
2024
202412. Generalized lymphadenopathy mimicking lymphoma caused by tattoo pigment in a cosmetic worker
Guzel Dirim M., ALTAY A. Y., YEGEN G., ŞENKAL N.
INTERNAL AND EMERGENCY MEDICINE
, vol.19, no.8, pp.2363-2364, 2024 (SCI-Expanded)
2024
202413. LEP rs7799039 and LEPR rs1137101 gene variants are not associated with clinical features in patients with metabolic syndrome in the Turkish population.
Jabbarli M., Senkal N., Tuncel F. C., Oyaci Y., Guzel Dirim M., Kose M., et al.
Laboratory medicine
, 2024 (SCI-Expanded)
2024
202414. Simultaneous pericardial and pleural effusion as a rare first manifestation of giant cell arteritis.
Guzel Dirim M., Mammadzada L., Senkal N., Medetalibeyoglu A., Kose M.
Internal and emergency medicine
, vol.19, no.4, pp.1161-1162, 2024 (SCI-Expanded, Scopus)
2024
202415. Massive Splenomegaly With Thrombotic Infarction as an Initial Manifestation of Triple Diagnosis
Guzel Dirim M., Duman O., Senkal N., Medetalibeyoglu A., Kose M.
American Journal of Medicine
, vol.137, no.6, 2024 (SCI-Expanded)
2024
202416. Abdominal Kikuchi-Fujimoto disease: an unusual presentation of a rare disorder
Dirim M. G., Altay A. Y., ŞENKAL N., GÜLTEKİN B. A., Cosan S., Ercan L. D., et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
, vol.117, no.8, pp.610-611, 2024 (SCI-Expanded)
2023
202317. Evaluation of SARS-CoV-2-Positive Patients with Suspected Reinfection
Allahverdiyeva A., Ağaçfidan A., Dogan L., Önel M., Uysal H., Medetalibeyoğlu A., et al.
VIRUSES-BASEL
, vol.15, no.11, 2023 (SCI-Expanded, Scopus)
2023
202318. Investigation of the Effectiveness of Liraglutide in the Medical Treatment of Obesity
ALTINKAYNAK M., GÖKSOY SOLAK Y., ŞENKAL N., TOR Y. B., AKPINAR T. S., KÖSE M.
Sakarya Tıp Dergisi , vol.13, no.3, pp.334-339, 2023 (Peer-Reviewed Journal)
2023
202319. The suppressor of cytokine signaling-1 (SOCS1) gene polymorphism and promoter methylation correlate with the course of COVID-19.
Tukek T., PEHLİVAN S., Medetalibeyoglu A., Serin I., Oyacı Y., Arıcı H., et al.
Pathogens and global health
, vol.117, no.4, pp.392-400, 2023 (SCI-Expanded, Scopus)
2023
202320. Criteria for Hyperinflammation Developing in COVID-19: Analysis of 2 Cohorts From Different Periods of the Pandemic
Amikishiyev S., Gunver M. G., Bektas M., Aghamuradov S., Ince B., Koca N., et al.
ARTHRITIS & RHEUMATOLOGY
, vol.75, no.5, pp.664-672, 2023 (SCI-Expanded)
2023
202321. Acute Intermittent Porphyria Attack Triggered by COVID-19 Infection
Bardak A. E., Alada M. O., ŞENKAL N., Alibeyoglu A., KÖSE M.
CUREUS JOURNAL OF MEDICAL SCIENCE
, no.4, 2023 (ESCI)
2023
202322. ASSOCIATING eNOS GENE VARIANTS WITH COVID-19 SUSCEPTIBILITY IN THE TURKISH POPULATION
Şenkal N., Oyaci Y., Cebeci T., Konyaoğlu H., Köse M., Önel M., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, vol.86, no.1, pp.1-6, 2023 (ESCI, TRDizin)
2023
202323. Independent risk factors for COVID-19-associated coagulopathy
Tor Y., Ozbalak M. M., Kalayoglu-Besisik S., Aksoy E., Cagatay A., Gul A., et al.
European Review for Medical and Pharmacological Sciences
, vol.27, no.16, pp.7851-7860, 2023 (SCI-Expanded, Scopus)
2023
202324. Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital
FERHATOĞLU F., Kapağan T., Paksoy N., Ak N., Medetalibeyoğlu A., Şenkal N., et al.
Turk Onkoloji Dergisi
, vol.38, no.1, pp.82-91, 2023 (ESCI)
2023
202325. The effect of DNA repair gene variants on COVID-19 disease: susceptibility, severity, and clinical course
Senkal N., Serin I., PEHLİVAN S., Pehlivan M., Medetalibeyoglu A., Cebeci T., et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
, vol.42, no.8, pp.571-585, 2023 (SCI-Expanded, Scopus)
2023
202326. Prognostic and Predictive Value of Baseline Hypogammaglobulinemia for Chronic Lymphocytic Leukemia Prognosis and Complications
Kuş F., Bektaş M., Şenkal N., Çatma Y., Atalah F., Akyıldız A., et al.
Eurasian Journal of Medical Advances
, no.3, pp.33-39, 2023 (Peer-Reviewed Journal)
2023
202327. ASSESSMENT OF THE RANSON SCORE IN ACUTE PANCREATITIS: ITS VALUE IN AN EMERGENCY SETTING UPON ADMISSION AKUT PANKREATİTTE RANSON SKORUNUN DEĞERLENDİRİLMESİ: ACİL SERVİSE BAŞVURU ANINDA DEĞERİ
Şenkal N., Karahan L., Bardak A. E., Konyaoğlu H., Teberi̇K Kama E., İNci İ., et al.
Istanbul Tip Fakultesi Dergisi
, vol.86, no.3, pp.198-203, 2023 (ESCI, Scopus, TRDizin)
2023
202328. The effect of hereditary thrombotic factors and comorbidities on the severity of COVID-19 disease
Kose M., Senkal N., Konyaoglu H., Emet A., Oyaci Y., PEHLİVAN S., et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
, vol.27, no.1, pp.395-403, 2023 (SCI-Expanded)
2022
202229. Comparison of clinical characteristics and outcome measures of PCR-positive and PCR-negative patients diagnosed as COVID-19: Analyses focusing on the older adults
Senkal N., Bahat G., Medetalibeyoglu A., Cebeci T., Deniz D., Catma Y., et al.
EXPERIMENTAL GERONTOLOGY
, vol.170, 2022 (SCI-Expanded, Scopus)
2022
202230. Symptomatology and imaging findings in early post-Covid period: A comparative study in older vs younger patients
Bahat G., Medetalibeyoglu A., Senkal N., Cebeci T., Oren M. M., Basaran S., et al.
EXPERIMENTAL GERONTOLOGY
, vol.167, 2022 (SCI-Expanded, Scopus)
2022
202231. Immune modulation as a consequence of SARS-CoV-2 infection
Gelmez M. Y., Öktelik F. B., Tahralı İ., Yılmaz V., Küçüksezer U. C., Akdeniz N., et al.
FRONTIERS IN IMMUNOLOGY
, vol.13, 2022 (SCI-Expanded, Scopus)
2022
202232. Investigation of MBL2 and NOS3 functional gene variants in suspected COVID-19 PCR (-) patients.
Pehlivan S., Köse M., Mese S., Serin I., Senkal N., Oyacı Y., et al.
Pathogens and global health
, vol.116, no.3, pp.178-184, 2022 (SCI-Expanded, Scopus)
2022
202233. Acute kidney injury in hospitalized COVID-19 patients.
Kanbay M., Medetalibeyoglu A., Kanbay A., Cevik E., Tanriover C., Baygul A., et al.
International urology and nephrology
, vol.54, no.5, pp.1097-1104, 2022 (SCI-Expanded, Scopus)
2022
202234. Dipyridamole does not have any additive effect on the prevention of COVID-19 coagulopathy.
Kalayoglu Besisik S., Ozbalak M. M., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.
American journal of blood research
, vol.12, no.2, pp.54-59, 2022 (Peer-Reviewed Journal)
2022
202235. Severe vitamin D deficiency is associated with endothelial inflammation in healthy individuals even in the absence of subclinical atherosclerosis
Kose M., Senkal N., Tukek T., Cebeci T., Atalar S. C., Altinkaynak M., et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
, no.19, pp.7046-7052, 2022 (SCI-Expanded, Scopus)
2022
202236. Interstitial lung disease in patients with systemic lupus erythematosus: a cohort study
Senkal N., Kiyan E., Demir A. A., Yalcinkaya Y., Gül A., Inanc M., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.52, no.1, pp.76-82, 2022 (SCI-Expanded)
2022
202237. Would Tracking Coagulation Together with Inflamation Markers be a Prospect for COVID-19 Disease Prognosis?
MEDETALİBEYOĞLU A., Kaytaz M., Senkal N., Genc S., Aktar I., ÖMER B., et al.
CLINICAL LABORATORY
, vol.68, pp.1159-1166, 2022 (SCI-Expanded, Scopus)
2021
202138. COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?
ÇAKMAK R., TELCİ ÇAKLILI Ö., ÇELİK A. M., MUTLU Ü., Nasıfova V., SARIBEYLİLER G., et al.
Turkish Journal of Diabetes and Obesity
, vol.5, no.3, pp.279-284, 2021 (Peer-Reviewed Journal)
2021
202139. Is There a Link between Circadian Clock Protein PERIOD 3 (PER3) (rs57875989) Variant and the Severity of COVID-19 Infection?
Yesil Sayin G., Pehlivan S., Serin I., Medetalibeyoglu A., Kose M., Agacfidan A., et al.
Current medical science
, vol.41, no.6, pp.1075-1080, 2021 (Scopus)
2021
202140. PATIENT CHARACTERISTICS AND RISK FACTORS FOR MORTALITY IN 504 HOSPITALIZED PATIENTS DUE TO COVID-19
Medetalibeyoglu A., Ezirmik E., Senkal N., Bayrakdar S., Aktar I., Akas R., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, 2021 (ESCI)
2021
202141. High Levels of Circulating IL-6 and IL-8 Signature Can Predict COVID-19 Severity
Ozgur D., Karamese M., MEDETALİBEYOĞLU A., ALKAN O., Senkal N., Tutuncu E. E.
JUNDISHAPUR JOURNAL OF MICROBIOLOGY
, vol.14, no.10, 2021 (SCI-Expanded, Scopus)
2021
202142. Post-COVID-19 Management: Comprehensive Assessment at Post-COVID-19 Monitoring Centre
BAHAT-ÖZTÜRK G., Günaydın S., MEDETALİBEYOĞLU A., Çatma Y., ŞENKAL N., ÖREN M. M., et al.
European journal of geriatrics and gerontology (Online)
, vol.3, no.2, pp.101-107, 2021 (TRDizin)
2021
202143. PULMONARY INVOLVEMENT IN A SINGLE CENTER COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Senkal N., Kiyan E., Kocasoy-Orhan E., Demir A., Aydoğan S. M., Yalcinkaya Y., et al.
ANNALS OF THE RHEUMATIC DISEASES
, vol.80, pp.1191, 2021 (SCI-Expanded)
2021
202144. Wide QRS Complex and Lateral ST-T Segment Abnormality Are Associated With Worse Clinical Outcomes in COVID-19 Patients
Sonsoz M. R., ÖNCÜL A., ÇEVİK E., ORTA H., Yilmaz M., Govdeli E. A., et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
, vol.361, no.5, pp.591-597, 2021 (SCI-Expanded, Scopus)
2021
202145. Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection.
Medetalibeyoglu A., Bahat G., Senkal N., Kose M., Avcı K., Sayın G., et al.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
, vol.89, pp.104717, 2021 (SCI-Expanded, Scopus)
2021
202146. Initial complete blood count score and predicting disease progression in COVID-19 patients.
Ozbalak M. M., Kalayoglu Besisik S., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.
American journal of blood research
, vol.11, no.1, pp.77-83, 2021 (ESCI)
2021
202147. Serum Endocan Levels on Admission Are Associated With Worse Clinical Outcomes in COVID-19 Patients: A Pilot Study
Medetalibeyoglu A., Emet S., Kose M., Akpinar T. S., Senkal N., Catma Y., et al.
ANGIOLOGY
, vol.72, no.2, pp.187-193, 2021 (SCI-Expanded, Scopus)
2021
202148. Cardiovascular view of intermediate and high-risk COVID-19 patients: single-centre experience with low mortality and intensive care hospitalisation rates
Medetalibeyoglu A., Emet S., Senkal N., Aydogan M., Kose M., Tukek T.
CARDIOVASCULAR JOURNAL OF AFRICA
, vol.32, no.2, pp.79-86, 2021 (SCI-Expanded, Scopus)
2021
202149. Effect of Lipid Emulsion on the Improvement of Renal Damage in Colistin- Induced Nephrotoxicity.
Senkal N., Atasoy O., Caparali E. B., Erdogan M. A., Erbas O.
Current drug safety
, vol.16, no.3, pp.259-263, 2021 (ESCI)
2020
202050. Pulmonary Involvement in a Single Center Cohort of Patients with Systemic Lupus Erythematosus
Senkal N., KIYAN E., Kocasoy-Orhan E., Demir A., AYDOĞAN M., YALÇINKAYA Y., et al.
ARTHRITIS & RHEUMATOLOGY
, vol.72, 2020 (SCI-Expanded)
2020
202051. Older Adults Hospitalized with Covid-19: Clinical Characteristics and Early Outcomes from a Single Center in Istanbul, Turkey
MEDETALİBEYOĞLU A., Senkal N., KÖSE M., ÇATMA Y., Caparali E. B., ERELEL M., et al.
JOURNAL OF NUTRITION HEALTH & AGING
, vol.24, no.9, pp.928-937, 2020 (SCI-Expanded, Scopus)
2020
202052. Covid-19: Correlation of Early Chest Computed Tomography Findings With the Course of Disease.
Erturk Ş. M., Durak G., Ayyildiz H., Comert R. G., Medetalibeyoglu A., Senkal N., et al.
Journal of computer assisted tomography
, vol.44, no.5, pp.633-639, 2020 (SCI-Expanded, Scopus)
2020
202053. Characteristics of the initial patients hospitalized for COVID-19: a single-center report
Medetalibeyoğlu A., Şenkal N., Çapar G., Köse M., Tükek T.
Turkish journal of medical sciences
, vol.50, no.5, pp.1436-1439, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202054. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.
Şenkal N., Meral R., Medetalibeyoğlu A., Konyaoğlu H., Kose M., Tukek T.
Anatolian journal of cardiology
, vol.24, no.1, pp.21-29, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202055. The effect of liver test abnormalities on the prognosis of COVID-19.
Medetalibeyoglu A., Catma Y., Senkal N., Ormeci A., Cavus B., Kose M., et al.
Annals of hepatology
, vol.19, no.6, pp.614-621, 2020 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. Analysis genomic profiles of type 2 diabetes patients with COVID-19 by next-generation sequencing method in Turkish population
Cacına C., Çakiris A., Abacı N., Sırma Ekmekci S., Bayrak A. E., Medetalibeyoğlu A., et al.
49th FEBS Congress, İstanbul, Turkey, 5 - 09 July 2025, vol.15, no.2, pp.112, (Summary Text)
2025
20252. Acil Dahiliye Kliniğine Trombotik Mikroanjiyopati Tanısı ile Başvuran Hastaların Tanısal Dağılımı: Tek Merkez Deneyimi
DENİZ D., GÜZEL DİRİM M., YILMAZ B., ERDEM S., ŞENKAL N., MEDETALİBEYOĞLU A., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Turkey, 10 April 2025, pp.25-26, (Summary Text)
2024
20243. TIP 2 DIYABETES MELLITUS, KRONIK BÖBREK YETERSIZLIĞI VE KALP YETERSIZLIĞI TANISI OLAN HASTALARDA SGLT-2 İNHIBITÖRÜ TEDAVISI KULLANIMININ RETROSPEKTIF DEĞERLENDIRILMESI
Deniz D., Erkul B., Karakaya N. R., Can B., Kahvecioğlu E. D., Altınkaynak M., et al.
26. ULUSAL İÇ HASTALIKLARI KONGRESİ , Girne, Cyprus (Kktc), 2 - 06 October 2024, pp.162-163, (Summary Text)
2024
20244. GERIATRIK POPÜLASYONDA DEMIR +2 VE DEMIR +3 PREPARATLARININ ETKINLIĞI VE HASTA UYUMUNUN KARŞILAŞTIRILMASI
Deniz D., Küçük C., Emekdaş B., Şenkal N., Tükek T.
26. ULUSAL İÇ HASTALIKLARI KONGRESİ , Girne, Cyprus (Kktc), 2 - 06 October 2024, pp.135, (Summary Text)
2024
20245. Analysis of lncrna expression in patients with metabolic syndrome: an investigation based on RNA- sequencing data
Oyacı Y., Şenkal N., Medetalibeyoğlu A., Tuncel F. C., Köse M., Tükek T., et al.
European Human Genetics Conference, Berlin, Germany, 1 - 04 June 2024, pp.100-101, (Summary Text)
2024
20246. Is there a relationship between global 5-methylcytosine and 5-hydroxymethylcytosine levels and metabolic syndrome and its clinical findings?
Pehlivan S., Şenkal N., Oyacı Y., Teberik Kama E., Pehlivan M., Tükek T., et al.
European Human Genetics Conference, Berlin, Germany, 1 - 04 June 2024, pp.100-101, (Summary Text)
2024
20247. Analysis Of Small Non Coding RNA (sncRNA) Expression In Patients with Metabolic Syndrome: An Investigation Based On Small RNA-Sequencing Data
Şenkal N., Oyacı Y., Medetalibeyoğlu A., Sayın S., Pehlivan S.
4th International Conference On Health, Engineerıng and Applied Sciences, Paris, France, 12 - 14 April 2024, pp.56-58, (Full Text)
2023
20238. Metabolik Sendrom Hastalarında Adiponektin Gen Varyantlarının (rs17300539, rs266729 ve rs2241766) Araştırılması: Ön Çalışma
Pehlivan S., Şenkal N., Oyacı Y., Köse M., Medetalibeyoğlu A., Tükek T.
25. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 8 - 12 November 2023, pp.26-27, (Summary Text)
2023
20239. KORONER ARTER HASTALIĞI VE DİYABET BİRLİKTELİĞİNDE OBEZİTE PARADOKSU
Yavuz M. L., Aydoğan M., Şenkal N., Karaca Özer P., Emet S., Köse M., et al.
25. ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Turkey, 8 - 12 November 2023, pp.83, (Full Text)
2023
202310. Demir eksikliği ve D vitamini eksikliği ile başvuran hastaların demir ve D vitamini preparatlarına uyumu
Konyaoğlu H., Şenkal N., Tükek T.
3. Geleneksel Demir Kampı, İzmir, Turkey, 13 - 15 October 2023, pp.11, (Summary Text)
2023
202311. Could Telomere Length Be a Biomarker in Metabolic Syndrome?
Şenkal N., Tuncel F. C., Tükek T., Oyacı Y., Pehlivan M., Pehlivan S.
2nd Internatıonal Cankaya Congress, Ankara, Turkey, 28 - 29 September 2023, pp.20-22, (Full Text)
2023
202312. Is There A Relatıonshıp Between Adiponectın Variants And The Risk Of Non-Alcoholic Fatty Liver Dısease In The Turkish Population?
Şenkal N., Oyacı Y.
International Aegean Conferences-VIII, İzmir, Turkey, 23 - 25 September 2023, pp.10-13, (Full Text)
2023
202313. Bruselloz Enfeksiyonunun Nadir Görülen Klinik Formu: Nörobruselloz
Karaca D., Ük E., Altın S., Korkut Akyürek D., Şenkal N., Medetalibeyoğlu A., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri, Sakarya, Turkey, 9 - 12 March 2023, pp.2, (Full Text)
2023
202314. The role of IL4, PSGL-1, PER3, eNOS and XRCC4 VNTR polymorphisms in patients wşth metabolic syndromes: A pilot study
Şenkal N., Oyacı Y.
International Gevher Nesibe Health Sciences Conference-X, Ankara, Turkey, 3 - 05 February 2023, pp.10-12, (Full Text)
2022
202215. A CASE OF PSEUDOHYPERALDOSTERONISM ASSOCIATED WITH EXCESSIVE CONSUMPTION OF LIQUORICE
Altunok D., Çetin O., Bektaş E., Şenkal N., Yazıcı H., Köse M., et al.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 19 - 23 October 2022, pp.179, (Full Text)
2022
202216. COVID-19 İMMÜNOLOJİSİ İÇİN YENİ FİKİRLER: SİTOKİN SİNYALLEME BASKILAYICISI-1 (SOCS-1) GENİ rs33989964 POLİMORFİZMİ, GLOBAL DNA VE SOCS-1 GEN PROMOTÖRÜ METİLASYONU
Tükek T., Pehlivan S., Medetalibeyoğlu A., Serin İ., Oyacı Y., Arıcı H., et al.
7. ULUSLARARASI ERCİYES BİLİMSEL ARAŞTIRMALAR KONGRESİ, Kayseri, Turkey, 9 - 10 March 2022, pp.159-168, (Full Text)
2021
202117. Laboratory And In Sılıco Analysıs Of The Pathogenic Variant Of Interleukin-17 (Rs763780) In Patients Diagnosed Wıth Covid-19
Oyacı Y., Şenkal N., MEDETALİBEYOĞLU A., YEŞİL SAYIN G., KÖSE M., PEHLİVAN M., et al.
Vııı.International Congress Of Molecular Medicine, Turkey, 9 - 12 November 2021, pp.13-17, (Full Text)
2021
202118. Covid-19 Tanısı Konulan Hastalarda İnterlökin-17'nin Patojenik Varyantının (Rs763780) Laboratuvar Ve Siliko Analizi
Oyacı Y., Şenkal N., Medetalibeyoğlu A., Yeşil Sayın G., Köse M., Pehlivan M., et al.
VIII.International Congress Of Molecular Medicine, İstanbul, Turkey, 9 - 12 November 2021, pp.10, (Full Text)
2021
202119. COVID-19 PCR (-) Hastalarda Mbl2 Ve Nos3 Fonksiyonel Gen Varyantlarının Araştırılması
Pehlivan S., Köse M., Meşe S., Serin I., Şenkal N., Oyacı Y., et al.
Tıbbi Biyoloji ve Genetik Kongresi, İstanbul, Turkey, 28 - 31 October 2021, pp.105, (Summary Text)
2021
202120. DNA ONARIM GEN VARYANTLARI (XRCC4 VE XRCC1) İLE COVİD-19 ENFEKSİYONU ARASINDA BİR BAĞLANTI OLABİLİR Mİ?
SERİN İ., KÖSE M., PEHLİVAN S., ŞENKAL N., PEHLİVAN M., MEDETALİBEYOĞLU A., et al.
47. Ulusal Hematoloji Kongresi, Turkey, 4 - 07 November 2021, pp.358, (Full Text)
2021
202121. İLK TANI PCR (-) COVİD-19 HASTALARINDA MBL2 VE NOS3 FONKSİYONEL GEN VARYANTLARININ ARAŞTIRILMASI
SERİN İ., PEHLİVAN S., KÖSE M., MEŞE S., ŞENKAL N., OYACI Y., et al.
47. Ulusal Hematoloji Kongresi, Antalya, Turkey, 4 - 07 November 2021, pp.357, (Full Text)
2021
202122. PERIOD 3 (PER3) (RS57875989) VARYANTI İLE COVİD-19 ENFEKSİYONUNUN ŞİDDETİ ARASINDA BİR BAĞLANTI OLABİLİR Mİ?
SERİN İ., PEHLİVAN S., KÖSE M., ŞENKAL N., OYACI Y., MEDETALİBEYOĞLU A., et al.
47. Ulusal Hematoloji Kongresi, Turkey, 4 - 07 November 2021, pp.379, (Full Text)
2021
202123. Covid-19-İlişkili Makrofaj Aktivasyon Sendromlu Hastalarda Tosilizumab Tedavisine Yanıtı Öngören Parametrelerin Araştırılması
AMİKİSHİYEV S., BEKTAŞ M., GÜVEN GÜNVER M., İNCE B., AGHAMURADOV S., KOCA N., et al.
ROMATOLOJİDE HEDEF 2021 SEMPOZYUMU, İstanbul, Turkey, 27 - 30 October 2021, pp.23-24, (Summary Text)
2021
202124. Preliminary Criteria for Macrophage Activation SyndromeAssociated with Coronavirus Disease-19
Amikishiyev S., Günver M. G., Bektaş M., Aghamuradov S., İnce B., Koca N., et al.
American College of Rheumatology 2021, Arizona, United States Of America, 5 - 09 November 2021, vol.10, no.73, pp.1-4, (Summary Text)
2021
202125. COVID-19-İlişkili Makrofaj Aktivasyon Sendromu İçin Sınıflandırma Kriterleri Geliştirilmesi
AMİKİSHİYEV S., GÜVEN GÜNVER M., BEKTAŞ M., AGHAMURADOV S., İNCE B., KOCA N., et al.
21. ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 September - 03 October 2021, pp.162-163, (Summary Text)
2021
202126. Dna Onarım Gen Varyantları (Xrcc4 Ve Xrcc1) İle Covıd-19 Enfeksiyonu Arasında Bir Bağlantı Olabilir Mi?
Köse M., Serin I., Pehlivan S., Şenkal N., Pehlivan M., Medetalibeyoğlu A., et al.
Euroasıa Summıt 4th Internatıonal Applıed Scıence Congress, Odessa, Ukraine, 10 - 11 September 2021, vol.1, no.1, pp.125-132, (Full Text)
2021
202127. The potential role of innate lymphoid cells in COVID‐19 patients
Gelmez M. Y., Öktelik F. B., Tahralı İ., Yılmaz A., Akdeniz N., Küçüksezer U. C., et al.
6th European Congress of Immunology, Belgrade, Serbia, 1 - 04 September 2021, pp.135, (Summary Text)
2021
202128. COVID-19 Hastalarında Endotel Nitrik Oksit Sentetaz Geninin (rs1799983 ve Intron 4a/b VNTR) Fonksiyonel Varyantlarının Araştırılması
Şenkal N., Oyacı Y., Köse M., Medetalibeyoğlu A., Önel M., Yeşil Sayın G., et al.
International Symposium On Global Pandemics And Multidisciplinary Covid-19 Studies , Ankara, Turkey, 19 - 20 March 2021, pp.1-7, (Full Text)
2021
202129. Investigation of Functional Variants of the Endothelital Nitric Oxide Synthetase Gene (rs1799983 and Intron 4a / b VNTR) in COVID-19 Patients
Şenkal N., Oyacı Y., KÖSE M., MEDETALİBEYOĞLU A., YEŞİL SAYIN G., PEHLİVAN M., et al.
International Symposium On Global Pandemics And Multidisciplinary Covid-19 Studies, 19 - 20 March 2021, pp.1-7, (Full Text)
2021
202130. INVESTIGATION OF FUNCTIONAL VARIANTS OF THE ENDOTHELITAL NITRIC OXIDE SYNTHETASE GENE (rs1799983 AND INTRON 4a/b VNTR-27 BP) IN COVID-19 PATIENTS
ŞENKAL N., OYACI Y., KÖSE M., MEDETALİBEYOĞLU A., ÖNEL M., YEŞİL SAYIN G., et al.
International Symposium on Global Pandemics and Multidisciplinary Covid-19 Studies, Ankara, Turkey, 19 March 2021, (Full Text)
2021
202131. COVID-19 SEYRINDE KOAGÜLASYON PARAMETRELERI VE İNFLAMATUAR BELIRTEÇLERDEKI DEĞIŞIMLERIN HASTALIK ŞIDDETIYLE İLIŞKISI
MEDETALİBEYOĞLU A., KAYTAZ A. M., ŞENKAL N., AKIN A., GENÇ N. S., ÖMER B., et al.
Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme, İstanbul, Turkey, 11 March 2021, (Summary Text)
2021
202132. CASTLEMAN HASTALIĞI’NIN NADIR BIR FORMU: TAFRO SENDROMU
Ük E., DİRİM A. B., MEDETALİBEYOĞLU A., AKIN A., ŞENKAL N., ERDEM S., et al.
Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme, İstanbul, Turkey, 11 March 2021, (Summary Text)
2020
202033. INVESTIGATION OF MBL2 AND NOS3 FUNCTIONAL GENE VARIANTS IN SUSPECTED COVID-19 PCR (-) PATIENTS:
PEHLİVAN S., KÖSE M., MEŞE S., serin i., Şenkal N., oyacı y., et al.
Eurosia Summit, Congress on Scientific Researches and Recent Trends-7, Baku, Azerbaijan, 6 - 09 December 2020, pp.21-26, (Full Text)
2020
202034. INVESTIGATION OF MBL2 AND NOS3 FUNCTIONAL GENE VARIANTS IN SUSPECTED COVID-19 PCR (-) PATIENTS
PEHLİVAN S., KÖSE M., MEŞE S., SERİN İ., Şenkal N., Oyacı Y., et al.
EUROASIA Congress on Scientific Researches and Recent Trends-VII, Baku, Azerbaijan, 6 - 08 December 2020, vol.1, (Summary Text)
2020
202035. Sars-Cov-2 Enfekte Hastalarda Prolıferatıf Yanıt Değışımlerı
KÜÇÜKSEZER U. C., ÖKTELİK F. B., TAHRALI İ., YILMAZ A., AKDENİZ N., GELMEZ M. Y., et al.
XXV. Ulusal İmmünoloji Kongresi, Turkey, 20 - 22 November 2020
2020
202036. SARS-CoV-2 Enfekte Hastalarda Proliferatif Yanıt Değişimleri
Küçüksezer U. C., Öktelik F. B., Tahralı İ., Yılmaz A., Akdeniz N., Gelmez M. Y., et al.
25. Ulusal İmmünoloji Kongresi , 20 - 22 November 2020, pp.49, (Summary Text)
2020
202037. COVID-19 Hastalarında Doğal Lenfoid Hücrelerinin Rolü
Gelmez M. Y., Öktelik F. B., Tahralı İ., Yılmaz A., Akdeniz N., Küçüksezer U. C., et al.
25. Ulusal İmmünoloji Kongresi (Dijital Kongre), 20 - 22 November 2020, pp.40, (Summary Text)
2020
202038. BAŞVURU ANI TAM KAN SAYIMI PUANLAMASININ COVID-19 HASTALARINDA İLERLEYİCİ HASTALIĞI GÖSTERMEDE ROLÜ
ÖZBALAK M. M., BEŞIŞIK S., TOR Y. B., MEDETALİBEYOĞLU A., KÖSE M., Şenkal N., et al.
46. Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, (Summary Text)
2020
202039. Comparison of clinical characteristic and outcome measures of PCR positive and PCR negative patients diagnosed as Covid-19 analyses focusing on the older adults
MEDETALİBEYOĞLU A., BAHAT-ÖZTÜRK G., ŞENKAL N., KÖSE M., Çatma Y., YEŞİL Y., et al.
16th International E-Congress of the European Geriatric Medicine Society, 7 - 09 October 2020, (Summary Text)
2020
202040. Follow-up of patients after acute COVID-19: results on persistent symptoms and control imaging findings
MEDETALİBEYOĞLU A., BAHAT-ÖZTÜRK G., Catma Y., ÖREN M. M., Caparal E. B., Bayrakdar S., et al.
16th International E-Congress of the European Geriatric Medicine Society, 07 October 2020, (Summary Text)
2020
202041. Dipyridamole Added to Anticoagulant Prophylaxis: Decline in Poor Outcome of Clinically Severe Ill COVID-2019 Patients
BEŞIŞIK S., ÖZBALAK M. M., TOR Y. B., MEDETALİBEYOĞLU A., KÖSE M., Şenkal N., et al.
International Society on Thrombosis and Hemostasis Annual Congress 2020, 12 - 14 July 2020, (Summary Text)
2020
202042. COVID-19 İLİŞKİLİ SEREBROVASKÜLER OLAY VAKASI
MEDETALİBEYOĞLU A., ŞENKAL N.
Online International Conference of COVID-19 (CONCOVID), ONLİNE, 12 June 2020, (Summary Text)
2020
202043. COVID-19 İLİŞKİLİ MİYOKARDİT
ÇAĞATAY A. A., ŞENKAL N., Bayrakdar i. S., MEDETALİBEYOĞLU A.
Online International Conference of COVID-19 CONCOVID, İstanbul, Turkey, 12 June 2020, (Summary Text)
2016
201644. TİROZİN KİNAZ İNHİBİTÖRÜ (TKI) DİRENCİ VEYA İLAÇ KULLANIMINA UYUM SORUNU: KRONİK FAZ KML İMATİNİB ALTINDA APSELEŞMEYE İLERLEYEN DALAK İNFAKTI; OLGU SUNUMU
ŞENKAL N., ERDEM S., ÖZTÜRK C. K., İSTEMİHAN Z., KALAYOĞLU BEŞIŞIK S.
3. Hematolojik Onkoloji Kongresi, 21 - 24 September 2016, pp.67-69, (Summary Text)
Congress and Symposium Activities
01 October 2019 - 01 October 2019
01 October 2019 - 01 October 201921.Ulusal İç Hastalıkları Kongresi
Attendee
-Turkey
01 March 2019 - 01 March 2019
01 March 2019 - 01 March 2019Geleneksel İç Hastalıkları Günleri 2019
Attendee
-Turkey
01 October 2018 - 01 October 2018
01 October 2018 - 01 October 201820.Ulusal İç Hastalıkları Kongresi
Attendee
Antalya-Turkey
01 March 2018 - 01 March 2018
01 March 2018 - 01 March 2018Geleneksel İç Hastalıkları Günleri 2018
Attendee
Sakarya-Turkey
01 October 2017 - 01 October 2017
01 October 2017 - 01 October 2017Ulusul İç Hastalıkları Kongresi
Attendee
Antalya-Turkey
01 September 2017 - 01 September 2017
01 September 2017 - 01 September 2017Uzmandan Uzmana İç Hastalıkları Güncelleme Toplantısı
Attendee
-Turkey
01 March 2017 - 01 March 2017
01 March 2017 - 01 March 2017Geleneksel İç Hastalıkları Günleri 2017
Attendee
Sakarya-Turkey
01 December 2016 - 01 December 2016
01 December 2016 - 01 December 2016
Ulusal Diyabet Akademisi
Attendee
-Turkey
01 September 2016 - 01 September 2016
01 September 2016 - 01 September 2016